type here...

CATEGORIES

Press Release

LATEST

1...8910...12Page 9 of 12

TRENDING

EDITORS CHOICE

St. Jude scientists identify possible COVID-19 treatment in the lab

Medika Life -
If validated, the discovery by St Jude scientists could offer real tools to deal with hyperinflammatory immune responses, one of the leading causes of death in Covid-19 infections

Trials Validate Cognition Improvement Using PrimeMyBody Hemp Extract

Medika Life -
Clinical brain mapping screenings of former NFL players who suffer from cognitive deficits provide supportive data that PrimeMyBody's FOCUS Mind & Body Hemp Extract improved brain performance for 80 percent of screening participants

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

Medika Life -
ZEPOSIA, a treatment for multiple sclerosis is the first and only approved sphingosine-1-phosphate (S1P) receptor modulator with no genetic test or first dose observation at initiation

Evrysdi™ Approved for Spinal Muscular Atrophy Home Treatment

Medika Life -
The FDA has approved Evrysdi™ (risdiplam), the first at-home, orally administered treatment for spinal muscular atrophy in children and adults

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories